TrialArthritis & rheumatology (Hoboken, N.J.)2018

Efficacy and Safety of Subcutaneous Belimumab in Anti-Double-Stranded DNA-Positive, Hypocomplementemic Patients With Systemic Lupus Erythematosus.

A Doria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.